Fiche publication
Date publication
juillet 2008
Auteurs
Membres identifiés du Cancéropôle Est :
Pr LANG Hervé
Tous les auteurs :
Cornu JN, Roupret M, Lang H, Long JA, Neuzillet Y, Patard JJ, Piechaud T, Correas JM, de Fromont M, Escudier B, Mejean A
Lien Pubmed
Résumé
In case of a single renal cell carcinoma strictly located in the kidney, the radical nephrectomy remains the treatment of choice. However, it has been estimated that nearly 30 to 40 % of renal cell carcinoma are about to recur after primitive surgery. In certain cases, conservative surgery can be discussed as an alternative to radical treatment, especially in case of exophytic renal tumour or less than 4 cm in diameter. New ablative techniques (radiofrequency and cryoablation) have shown promising results but the follow-up is still very limited. French national recommendation regarding kidney cancer have been updated in 2007 and following the development of clinical trials using antiangiogenic agents. Regarding the use of antiangiogenic agents, several points have to be taken into account : existence of renal cell carcinoma, presence of metastasis, number of metastasis, location and risk factor prognosis determination. (C) 2008 Elsevier Masson SAS. All rights reserved.
Référence
Prog Urol. 2008 Jul;18 Suppl 4:S81-7.
